Company

InventisBio

As of the edition of 20 October 2026, InventisBio runs 7 drugs.

Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.

Drugs by status

StatusCount
Active7
Total7

Where its trials are

  • Cancer: 6 trials led
  • Skin and connective tissue: 5 trials led
  • Bones, joints and muscles: 4 trials led